Latest Breaking News On - Biomed pharmacother - Page 1 : comparemela.com

Connections Between Food Additives and Psychiatric Disorders

What are the connections between what we eat and disorders such as anxiety and depression?

University of hong kongHong kong generalHong kongBiomed pharmacotherEndocrinol lettLuzeena rajaDivya subhashreeSchool of chinese medicineCommunity health equity resChild adolesc ment healthDrug administrationIntj environ res public healthPublic healthSun yat sen universityChinese medicineChina dr liis

Can Semaglutide Help in Psychiatry Too? Research Shows Promise for AD and PD

Available evidence from preclinical studies indicates that semaglutide shows promise for treating Alzheimer disease and Parkinson disease.

Creighton universityUnited statesNew havenJ clin neurosciNaeblys adobestockAlzheimers dementBiomed pharmacotherOslo university hospitalBanner alzheimer instituteUniversity of arizona college medicineAlzheimer disease cooperative studyYale school of medicineDrug administrationIntj environ res public healthDisease cooperative study activitiesParkinson disease

For a Healthy Heart: Tilapia May be bad - The Chronicle News Online

For a Healthy Heart: Tilapia May be bad - The Chronicle News Online
thechronicle.com.gh - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thechronicle.com.gh Daily Mail and Mail on Sunday newspapers.

United statesGhana generalBiomed pharmacotherRaphael nyarkotey obuNutrition committeeNyarkotey college of holistic medicine technologyAmerican heart associationAfrican naturopathic foundationProf raphael nyarkotey obuNaturopathic healthcareMedical journalistNyarkotey collegeHolistic medicineAmerican heartAcid ratio increases

Exploring the Landscape of Gene Therapy

An overview of how gene therapy has evolved since its inception, current applications, and emerging challenges.

United statesUniversity of washingtonUniversity of pennsylvaniaJesse gelsingerMichaelidesm leberSean hwangSamantha culwellAnneliese schuesslerBiomed pharmacotherBristol myers squibbDaich varelaFred hutchinson cancer centerUniversity of washington medicineKite pharmaBluebird bioSpark therapeutics

Early Trials of PRMT5 Inhibitors Leave Much to Be Desired, But Optimism Remains

Despite the discovery of protein arginine methyltransferase 5 more than 20 years ago, interest in the potential oncogene as a treatment target for patients with hematologic and solid malignancies has increased in recent years with the advancement of multiple novel agents through preclinical and early-phase studies.

United statesBiomed pharmacotherUlrikn lassenVarun mongaAmerican society of hematology annual meeting expositionUniversity of copenhagenAmerican society of clinical oncologyAmerican association for cancer research annual meetingDepartment of internal medicineDepartment of clinical medicineEuropean society for medical oncology congressUniversity of iowa carver college medicinePhase studiesDisplay mixedClinical trialsClinical oncology